Evidence map›Paper›PMID 35643386›Full record

ArticleBiochimica et biophysica acta. Molecular basis of disease2022

Methamphetamine induces thoracic aortic aneurysm/dissection through C/EBPβ.

Bao-Ying Luo, Jie Zhou, Dan Guo, Qian Yang, Qin Tian, Dun-Peng Cai, Rui-Mei Zhou, Zhen-Zhen Xu, Hui-Jun Wang, Shi-You Chen and 1 more

Open access · greenAbstract read
In one paragraph

Article in Biochimica et biophysica acta. Molecular basis of disease, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Bao-Ying LuoGuangzhou Key Laboratory of Forensic Multi-Omics for Precision Identification, School of Forensic Medicine, Southern Medical University, Guangzhou 510515, PR China; Zhangzhou Health Vocational College, Zhangzhou 363000, PR China.
Jie ZhouGuangzhou Key Laboratory of Forensic Multi-Omics for Precision Identification, School of Forensic Medicine, Southern Medical University, Guangzhou 510515, PR China.
Dan GuoDepartment of Pharmacy, Nanfang Hospital, Southern Medical University, Guangzhou 510515, PR China.
Qian YangGuangzhou Key Laboratory of Forensic Multi-Omics for Precision Identification, School of Forensic Medicine, Southern Medical University, Guangzhou 510515, PR China.
Qin TianGuangzhou Key Laboratory of Forensic Multi-Omics for Precision Identification, School of Forensic Medicine, Southern Medical University, Guangzhou 510515, PR China.
Dun-Peng CaiDepartment of Surgery, Medical Pharmacology & Physiology, University of Missouri School of Medicine, Columbia, MO 65212, USA.
Rui-Mei ZhouDepartment of Surgery, Medical Pharmacology & Physiology, University of Missouri School of Medicine, Columbia, MO 65212, USA.
Zhen-Zhen XuGuangzhou Key Laboratory of Forensic Multi-Omics for Precision Identification, School of Forensic Medicine, Southern Medical University, Guangzhou 510515, PR China.
Hui-Jun WangGuangzhou Key Laboratory of Forensic Multi-Omics for Precision Identification, School of Forensic Medicine, Southern Medical University, Guangzhou 510515, PR China. Electronic address: hjwang711@yahoo.cn.
Shi-You ChenDepartment of Surgery, Medical Pharmacology & Physiology, University of Missouri School of Medicine, Columbia, MO 65212, USA. Electronic address: scqvd@missouri.edu.
Wei-Bing XieGuangzhou Key Laboratory of Forensic Multi-Omics for Precision Identification, School of Forensic Medicine, Southern Medical University, Guangzhou 510515, PR China; NHC Key Laboratory of Drug Addiction Medicine, The First Affiliated Hospital of Kunming Medical University, Kunming, PR China. Electronic address: xwb@smu.edu.cn.
Southern Medical University · CNUniversity of Missouri · USKunming Medical University · CNNanfang Hospital · CNZhangzhou Vocational and Technical College · CN

Funding

Novel mechanism of smooth muscle phenotypic modulation and vascular remodelingR01HL119053 · NHLBI · UNIVERSITY OF MISSOURI-COLUMBIA · PI CHEN, SHIYOU · 2014 to 2023
$3.8M
NHLBI NIH HHS R01 HL119053
6 · The paper itself

Abstract

aimsThoracic aortic aneurysm/dissection (TAAD) is a life-threatening disease with diverse clinical manifestations. Although the association between methamphetamine (METH) and TAAD is frequently observed, the causal relationship between METH abuse and aortic aneurysm/dissection has not been established. This study was designed to determine if METH causes aortic aneurysm/dissection and delineate the underlying mechanism. METHODS AND

resultsA new TAAD model was developed by exposing METH to SD rats pre-treated with lysyl oxidase inhibitor β-aminopropionitrile (BAPN). Combination of METH and BAPN caused thoracic aortic aneurysm/dissection in 60% of rats. BAPN+METH significantly increased the expression and activities of both matrix metalloproteinase MMP2 and MMP9, consistent with the severe elastin breakage and dissection. Mechanistically, METH increased CCAAT-enhancer binding protein β (C/EBPβ) expression by enhancing mothers against decapentaplegic homolog 3 (Smad3) and extracellular regulated protein kinase (ERK1/2) signaling. METH also promoted C/EBPβ binding to MMP2 and MMP9 promoters. Blocking C/EBPβ significantly attenuated METH+BAPN-induced TAAD and MMP2/MMP9 expression. Moreover, BAPN+METH promoted aortic medial smooth muscle cell (SMC) apoptosis through C/EBPβ-mediated IGFBP5/p53/PUMA signaling pathways. More importantly, the expression of C/EBPβ, MMP2/MMP9, and apoptosis-promoting proteins was increased in the aorta of human patients with thoracic aortic dissection, suggesting that the mechanisms identified in animal study could be relevant to human disease.

conclusionsOur study demonstrated that METH exposure has a casual effect on TAAD. C/EBPβ mediates METH-introduced TAAD formation by causing elastin breakage, medial cell loss and degeneration. Therefore, C/EBPβ may be a potential factor for TAAD clinical diagnosis or treatment.

Indexed as

Aortic Aneurysm, ThoracicAortic DissectionMethamphetamineAminopropionitrileAnimalsCCAAT-Enhancer-Binding Protein-betaElastinHumansMatrix Metalloproteinase 2Matrix Metalloproteinase 9RatsRats, Sprague-DawleyAminopropionitrileCCAAT-Enhancer-Binding Protein-betaCebpb protein, ratElastinMatrix Metalloproteinase 2Matrix Metalloproteinase 9MethamphetamineApoptosisC/EBPβMethamphetamineMMP2/9Thoracic aortic aneurysm/dissection

Identifiers

PMID35643386
PMCPMC9753351
OpenAlexW4281633634

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.